11 August 2022 · Clonidine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Vancomycin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Methotrexate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Ropivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Diamorphine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Fluorescein products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Hydrocortisone acetate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Omnipaque products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · The intrathecal route is a high risk route of administration. It is essential to consider the properties of the medicinal product when assessing the risk